Back to VA VANGUARD CAPITAL MANAGEMENT LLC
TCRX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in TSCAN THERAPEUTICS INC
Yes. Vanguard Capital Management holds 2,158,831 shares of TCRX (Tscan Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. It increased the position by 4,575 shares (+0.2%) from Q1 2026. Vanguard Capital Management has held TCRX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$2.1M
Current Shares
2.2M
Total Value Change
-$60,145
Total Shares Change
+4,575
Quarter-by-Quarter History
Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BlackRock, Inc.